The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP FIGI (to the nearest dollar) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ISHARES INC CORE MSCI EMKT 46434G103   17,184,892 361,103 SH   SOLE   361,103 0 0
CARMELL THERAPEUTICS CORP CL A 142922103   371,329 103,061 SH   SOLE   103,061 0 0
DUOLINGO INC CL A COM 26603R106   60,926,373 367,314 SH   SOLE   367,314 0 0
NEUBASE THERAPEUTICS INC. COM 64132K102   40,855 46,970 SH   SOLE   46,970 0 0
PREDICTIVE ONCOLOGY INC. COM NEW 74039M200   33,146 10,358 SH   SOLE   10,358 0 0
VERA THERAPEUTICS INC. CL A 92337R101   220,183 16,060 SH   SOLE   16,060 0 0
INNSUITES HOSPITALITY TRUST SH BEN INT 457919108   12,700 10,000 SH   SOLE   10,000 0 0